The US drug regulator has approved the first cannabis-based epilepsy treatment for children as young as two. – Katar Investments

News

The US drug regulator has approved the first cannabis-based epilepsy treatment for children as young as two.

Nasdaq-listed GW Pharmaceuticals, which grows its own marijuana plants in glass houses in Britain, hopes the drug will be approved in the UK next year.

The company’s chief executive Justin Gover told Ian King Live last week: “This is a new breakthrough in the field of childhood-onset epilepsy. This treatment we have studied for the last five years.

“It has shown in placebo trials it can reduce seizures in certain types of childhood-onset epilepsy and we believe it would a breakthrough in the US and hopefully in the UK next year.”

 

Please read the full article HERE